Tag: UK life sciences
Russell Abberley named Acting ABPI President as Susan Rienow becomes Pfizer CMO
As Acting ABPI President, he will focus on improving the UK’s international competitiveness in research, development, and the launch of innovative medicines
Russell Abberley, General...
£400 million VPAG investment programme launched to boost UK’s clinical trials
This new investment programme will lead to the creation of 18 new clinical trials hubs across UK to accelerate research
The UK government has announced...
UK life sciences failing to reach its potential despite high R&D investment, new report reveals
Wes Streeting recently announced his plans to bolster the economy through the life sciences sector
“The UK remains genuinely world-leading for life sciences in...
ABPI outlines top priorities for Labour’s first 100 days in office
ABPI calls on Labour to urgently appoint a new Chair and Chief Executive to the Medicines and Healthcare products Regulatory Agency (MHRA)
The Association of...
New government consultation on medicine clawbacks will harm investment, says ABPI
The government has launched a consultation into radically changing the Statutory Scheme for branded medicines (known as the Statutory Scheme).
The consultation comes as delicate...
